The Expression Levels of MicroRNAs Differentially Expressed in Sudden Sensorineural Hearing Loss Patients’ Serum Are Unchanged for up to 12 Months after Hearing Loss Onset
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24087307 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Reyhaneh Abgoon und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Otolaryngology, Department of Surgery, University of British Columbia, Vancouver, BC V5Z 1M9, Canada. Hauptthemen laut MEDLINE: MicroRNAs, Hearing Loss, Sensorineural, Hearing Loss, Sudden, Deafness. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vancouver Coastal Health Research Institute.
Abstract (Originalsprache)
Sudden sensorineural hearing loss (SSNHL) is an acquired idiopathic hearing loss. Serum levels of small, non-coding RNAs and microRNAs (miRNAs) miR-195-5p/-132-3p/-30a-3p/-128-3p/-140-3p/-186-5p/-375-3p/-590-5p are differentially expressed in SSNHL patients within 28 days of hearing loss onset. This study determines if these changes persist by comparing the serum miRNA expression profile of SSNHL patients within 1 month of hearing loss onset with that of patients 3–12 months after hearing loss onset. We collected serum from consenting adult SSNHL patients at presentation or during clinic follow-up. We matched patient samples drawn 3–12 months after hearing loss onset (delayed group, n = 9 patients) by age and sex to samples drawn from patients within 28 days of hearing loss onset (immediate group, n = 14 patients). We compared the real-time PCR-determined expression levels of the target miRNAs between the two groups. We calculated the air conduction pure-tone-averaged (PTA) audiometric thresholds in affected ears at the initial and final follow-up visits. We undertook inter-group comparisons of hearing outcome status and initial and final PTA audiometric thresholds. There was no significant inter-group difference in miRNA expression level, hearing recovery status and initial and final affected ear PTA audiometric thresholds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Otolaryngology, Department of Surgery, University of British Columbia, Vancouver, BC V5Z 1M9, Canada.
- Vancouver Coastal Health Research Institute, Vancouver, BC V5Z 1M9, Canada.
- Department of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, BC V5Z 1L3, Canada.
- Division of Otolaryngology-Head & Neck Surgery, Vancouver General Hospital, Vancouver, BC V57 1M9, Canada.
ORCID-Profile: Reyhaneh Abgoon, Printha Wijesinghe, Desmond A Nunez
Förderung
- Vancouver Coastal Health Research Institute
Zitieren
APA
Abgoon, R., Wijesinghe, P., Garnis, C., & Nunez, D. A. (2023). The Expression Levels of MicroRNAs Differentially Expressed in Sudden Sensorineural Hearing Loss Patients’ Serum Are Unchanged for up to 12 Months after Hearing Loss Onset. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24087307
Vancouver
Abgoon R, Wijesinghe P, Garnis C, Nunez DA. The Expression Levels of MicroRNAs Differentially Expressed in Sudden Sensorineural Hearing Loss Patients’ Serum Are Unchanged for up to 12 Months after Hearing Loss Onset. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24087307
BibTeX
@article{Abgoon2023,
author = {Abgoon, Reyhaneh and Wijesinghe, Printha and Garnis, Cathie and Nunez, Desmond A},
title = {The Expression Levels of MicroRNAs Differentially Expressed in Sudden Sensorineural Hearing Loss Patients’ Serum Are Unchanged for up to 12 Months after Hearing Loss Onset},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24087307}
}
EUVIMED